News

BREAKING NEWS: Encouraging Results for New Breast Cancer Treatment

Publish date: October 8, 2010
By
Robert Finn

 

Trastuzumab-DM1 (T-DM1), a new type of targeted therapy for breast cancer, has shown encouraging results as a first-line treatment for metastatic breast cancer. Study results were presented today at a meeting of the European Society for Medical Oncology in Milan. More details to come.

Recommended Reading

Older Mid-Pack Marathoners Show No Sustained Heart Damage
MDedge Internal Medicine
10-Year Breast Cancer Survival Rates Improve
MDedge Internal Medicine
Breast Cancer Mortality Reduced by 26% With Mammography
MDedge Internal Medicine
Study Predicts Large Increase in Surgeries for Stress Incontinence and Pelvic Floor Prolapse
MDedge Internal Medicine
Current and Former Smoking Pose Large PAD Risks in Women
MDedge Internal Medicine
Age, Tumor Characteristics Predict Locoregional Failure After Neoadjuvant Breast Cancer Therapy
MDedge Internal Medicine
BRASS Registry Enables Clinical, Genetic Research in Rheumatoid Arthritis
MDedge Internal Medicine
Oophorectomy Halves Risk of Contralateral Breast Cancer with BRCA Mutations
MDedge Internal Medicine
Long-Term Breast Radiotherapy Trials at Odds Over Risk of Second Malignancies
MDedge Internal Medicine
Experts Support Nearly Universal Flu Vaccination for 2010-2011
MDedge Internal Medicine